Monitor for any subsequent prospectus supplement or takedown notice, which would signal an actual offering. The shelf becoming effective is a procedural step; the stock is unlikely to react until a specific offering is announced.
Price Chart
Executive Summary
Palisade Bio's $300M universal shelf registration (File No. 333-295815) became effective on May 21, 2026, enabling the company to offer and sell securities at any time. The company had $132.6M in cash as of March 31, 2026, and management has stated existing cash funds operations through key Phase 2 readouts in 2H 2027 and early 2028, suggesting this is an opportunistic shelf filing rather than an imminent dilutive event.
Key Facts
- Shelf registration (File No. 333-295815) declared effective on May 21, 2026.
- Company reported $132.6M in cash as of March 31, 2026.
- Management states existing cash funds operations through Phase 2 readouts in 2H 2027 and early 2028.
- Shelf provides maximum flexibility for future capital raises but no immediate offering announced.
Financial Impact
Up to $300M in potential future offerings, but no immediate dilution as no takedown has occurred.
Risk Factors
- Potential future dilution if the company conducts an offering under the shelf.
- Market may perceive shelf effectiveness as overhang, especially for a pre-revenue biotech.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001731 |
| Document: 9999999995-26-001731-index.html | 9999999995-26-001731 |
| Document: 9999999995-26-001731.txt | 9999999995-26-001731 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 10, 2026 7w ago | 8-K | $2.14 $2.05 | ▼ −4.21% | ▼ −3.15% | $1.45 (−32.48%) |
Jul 10, 2026 11w ago | Insider Cluster | $1.89 $2.10 | ▲ +11.11% | ▲ +7.93% | $1.45 (−23.54%) |
Jul 8, 2026 12w ago | Insider Cluster | $1.97 $2.09 | ▲ +6.09% | ▲ +3.85% | $1.45 (−26.65%) |
Jun 11, 2026 16w ago | 8-K | $1.71 $1.96 | ▲ +14.62% | ▲ +12.84% | $1.45 (−15.50%) |
May 22, 2026 19w ago | EFFECT | $1.95 $1.89 | ▼ −3.08% | ▼ −1.66% | $1.45 (−25.90%) |
May 12, 2026 20w ago | S-3 | $1.87 $1.78 | ▼ −4.81% | ▼ −4.20% | $1.45 (−22.73%) |
Apr 29, 2026 22w ago | DEFA14A | $2.00 $2.12 | ▲ +6.00% | ▲ +0.77% | $1.45 (−27.75%) |
Apr 2, 2026 26w ago | 8-K | $1.89 $2.00 | ▲ +5.82% | ▼ −4.06% | $1.45 (−23.54%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access